Profile
Ed Bell worked as an Investor Relations Contact at CTI BioPharma Corp.
from 2008 to 2018.
Former positions of Ed Bell
| Companies | Position | End |
|---|---|---|
| CTI BIOPHARMA CORP. | Investor Relations Contact | 2018-03-31 |
Experiences
Positions held
Connections
22
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Ed Bell
